NO174465C - Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1-acyl-2,3-dihydro-4-(1H)-kinolinon-4-oksimderivater - Google Patents
Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1-acyl-2,3-dihydro-4-(1H)-kinolinon-4-oksimderivaterInfo
- Publication number
- NO174465C NO174465C NO875495A NO875495A NO174465C NO 174465 C NO174465 C NO 174465C NO 875495 A NO875495 A NO 875495A NO 875495 A NO875495 A NO 875495A NO 174465 C NO174465 C NO 174465C
- Authority
- NO
- Norway
- Prior art keywords
- quinolinone
- dihydro
- acyl
- therapeutically active
- oxime derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/36—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10284786 | 1986-05-02 | ||
| JP62092788A JPS63239270A (ja) | 1986-05-02 | 1987-04-15 | １−アシル−２，３−ジヒドロ−４（１ｈ）−キノリノン−４−オキシム誘導体、その製法、およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去剤 |
| PCT/JP1987/000276 WO1987006580A1 (fr) | 1986-05-02 | 1987-05-01 | Derives de 1-acyl-2,3-dihydro-4(1h)-quinolinone-4-oxime |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO875495D0 NO875495D0 (no) | 1987-12-30 |
| NO875495L NO875495L (no) | 1988-03-01 |
| NO174465B NO174465B (no) | 1994-01-31 |
| NO174465C true NO174465C (no) | 1994-05-11 |
Family
ID=26434165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO875495A NO174465C (no) | 1986-05-02 | 1987-12-30 | Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1-acyl-2,3-dihydro-4-(1H)-kinolinon-4-oksimderivater |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US4839368A (fr) |
| EP (1) | EP0243982B1 (fr) |
| AU (2) | AU596657B2 (fr) |
| CA (1) | CA1314888C (fr) |
| DE (1) | DE3769358D1 (fr) |
| DK (1) | DK171379B1 (fr) |
| ES (1) | ES2036542T3 (fr) |
| FI (1) | FI90071C (fr) |
| GR (1) | GR3001800T3 (fr) |
| HU (1) | HU199803B (fr) |
| IE (1) | IE60105B1 (fr) |
| IL (1) | IL82399A0 (fr) |
| NO (1) | NO174465C (fr) |
| NZ (1) | NZ220168A (fr) |
| RU (1) | RU1779246C (fr) |
| SU (1) | SU1722227A3 (fr) |
| WO (1) | WO1987006580A1 (fr) |
| ZW (1) | ZW7887A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4839368A (en) * | 1986-05-02 | 1989-06-13 | Mochida Pharmaceutical Co., Ltd. | 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives |
| JP2602037B2 (ja) * | 1987-10-31 | 1997-04-23 | 持田製薬株式会社 | １−アシル−２，３−ジヒドロ−４（１ｈ）−キノリノン−４−オキシム誘導体、その製法およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去用医薬組成物 |
| TW234124B (fr) * | 1992-07-15 | 1994-11-11 | Sumitomo Chemical Co | |
| DE69535486T2 (de) | 1994-06-15 | 2008-04-10 | Otsuka Pharmaceutical Co., Ltd. | Benzoheterocyclische Verbindungen verwendbar als Vasopressin- oder Oxytocin-Modulatoren |
| HN2000000203A (es) | 1999-11-30 | 2001-06-13 | Pfizer Prod Inc | Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas. |
| GB2532990A (en) | 2014-12-05 | 2016-06-08 | Schlumberger Holdings | Corrosion inhibition |
| GB2543498A (en) * | 2015-10-19 | 2017-04-26 | Schlumberger Holdings | Corrosion inhibition |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4013662A (en) * | 1974-12-19 | 1977-03-22 | Pfizer Inc. | Alkyl and benzyl 6,7-dialkoxy-2-methyl-4-oxo-1,2,3,4-tetrahydroquinoline-1-carboxylates |
| US3976650A (en) * | 1975-11-04 | 1976-08-24 | Pfizer Inc. | Process for preparing optically active 6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoline carboxylic acid ester analgesics |
| US4260764A (en) * | 1976-12-22 | 1981-04-07 | Pfizer Inc. | 9-Hydroxyoctahydrobenzo [C] quinolines and intermediates therefor |
| US4421919A (en) * | 1980-07-28 | 1983-12-20 | Hodogaya Chemical Co., Ltd. | 4-Oximino-1,2,3,4-tetrahydroquinoline derivatives |
| GB2092130B (en) * | 1980-07-28 | 1984-05-10 | Hodogaya Chemical Co Ltd | 4-oximino-1,2,3,4-tetrahydroquinoline derivatives |
| GB2081091B (en) * | 1980-07-28 | 1984-03-07 | Mochida Pharm Co Ltd | Hypotensive diuretic pharmaceutical compositions containing tetrahydroquinoline derivatives |
| US4521607A (en) * | 1981-02-27 | 1985-06-04 | Takeda Chemical Industries, Ltd. | Chromanyl glycines |
| CA1189078A (fr) * | 1982-07-30 | 1985-06-18 | Hodogaya Chemical Co., Ltd. | Methode de preparation de derives de 4-oximo-1,2,3,4- tetrahydroquinoline; derives ainsi obtenus |
| DE3416695A1 (de) * | 1984-05-05 | 1985-11-07 | Bayer Ag, 5090 Leverkusen | Amidinohydrazone von tetralin-, chromon-, thiochromon- und tretrahydrochinolin-derivaten, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| PH21213A (en) * | 1984-10-26 | 1987-08-21 | Fujisawa Pharmaceutical Co | Benzene- and pyrazole- fused heterocyclic compound and pharmaceutical composition comprising the same |
| EP0199672B1 (fr) * | 1985-04-12 | 1988-06-01 | Ciba-Geigy Ag | Sulfonates d'oximes contenant des groupes réactifs |
| US4839368A (en) * | 1986-05-02 | 1989-06-13 | Mochida Pharmaceutical Co., Ltd. | 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives |
-
1987
- 1987-04-27 US US07/042,784 patent/US4839368A/en not_active Expired - Fee Related
- 1987-04-30 EP EP87106373A patent/EP0243982B1/fr not_active Expired - Lifetime
- 1987-04-30 ES ES198787106373T patent/ES2036542T3/es not_active Expired - Lifetime
- 1987-04-30 ZW ZW78/87A patent/ZW7887A1/xx unknown
- 1987-04-30 DE DE8787106373T patent/DE3769358D1/de not_active Expired - Lifetime
- 1987-05-01 HU HU872931A patent/HU199803B/hu not_active IP Right Cessation
- 1987-05-01 IL IL82399A patent/IL82399A0/xx not_active IP Right Cessation
- 1987-05-01 AU AU72441/87A patent/AU596657B2/en not_active Ceased
- 1987-05-01 WO PCT/JP1987/000276 patent/WO1987006580A1/fr not_active Ceased
- 1987-05-01 CA CA000536174A patent/CA1314888C/fr not_active Expired - Fee Related
- 1987-05-01 NZ NZ220168A patent/NZ220168A/xx unknown
- 1987-05-11 IE IE115487A patent/IE60105B1/en not_active IP Right Cessation
- 1987-12-30 SU SU874203894A patent/SU1722227A3/ru active
- 1987-12-30 FI FI875771A patent/FI90071C/fi not_active IP Right Cessation
- 1987-12-30 DK DK694487A patent/DK171379B1/da active
- 1987-12-30 NO NO875495A patent/NO174465C/no unknown
-
1988
- 1988-12-23 RU SU884613166A patent/RU1779246C/ru active
-
1989
- 1989-01-25 US US07/301,125 patent/US5077410A/en not_active Expired - Fee Related
-
1990
- 1990-07-02 AU AU58618/90A patent/AU630716B2/en not_active Ceased
-
1991
- 1991-04-18 GR GR91400134T patent/GR3001800T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE871154L (en) | 1987-11-02 |
| NO875495L (no) | 1988-03-01 |
| RU1779246C (ru) | 1992-11-30 |
| ES2036542T3 (es) | 1993-06-01 |
| HUT47912A (en) | 1989-04-28 |
| GR3001800T3 (en) | 1992-11-23 |
| CA1314888C (fr) | 1993-03-23 |
| FI90071C (fi) | 1993-12-27 |
| FI90071B (fi) | 1993-09-15 |
| EP0243982B1 (fr) | 1991-04-17 |
| NZ220168A (en) | 1990-02-26 |
| WO1987006580A1 (fr) | 1987-11-05 |
| DK171379B1 (da) | 1996-10-07 |
| US5077410A (en) | 1991-12-31 |
| FI875771A7 (fi) | 1987-12-30 |
| AU630716B2 (en) | 1992-11-05 |
| IE60105B1 (en) | 1994-06-01 |
| AU5861890A (en) | 1990-11-15 |
| AU7244187A (en) | 1987-11-05 |
| ZW7887A1 (en) | 1987-09-09 |
| DK694487A (da) | 1988-03-02 |
| SU1722227A3 (ru) | 1992-03-23 |
| NO174465B (no) | 1994-01-31 |
| US4839368A (en) | 1989-06-13 |
| FI875771A0 (fi) | 1987-12-30 |
| IL82399A0 (en) | 1987-11-30 |
| NO875495D0 (no) | 1987-12-30 |
| DK694487D0 (da) | 1987-12-30 |
| AU596657B2 (en) | 1990-05-10 |
| EP0243982A1 (fr) | 1987-11-04 |
| HU199803B (en) | 1990-03-28 |
| DE3769358D1 (de) | 1991-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO174385C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive spiro-substituerte glutamid-derivater | |
| NO177387C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive imidazo-kondenserte, 6-leddede, heterocykliske forbindelser | |
| NO163131C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridinderivater. | |
| NO174547C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive didehydro-vitamin-D3-derivater | |
| NO180586C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler | |
| NO176759C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater | |
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| FI91152B (fi) | Menetelmä terapeuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| NO172540C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrrolderivater | |
| NO173544C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2- tiometyl-substituerte 1,4-dihydropyridiner | |
| NO173545C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolinderivater | |
| NO170884C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrimidinderivater | |
| FI883739A7 (fi) | Menetelmä terapeuttisesti aktiivisten fenoksi-indaanimetyyliamiinijohdannaisten valmistamiseksi | |
| NO176319C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive furanderivater | |
| NO178498C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive karbapenemderivater | |
| NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
| NO178543C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive benzopyranderivater | |
| NO180084C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater | |
| NO166083C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater. | |
| NO165841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater. | |
| NO176713C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater | |
| NO175429C (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive 16-dehydro-vitamin-D3-derivater | |
| NO177096C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte isokinoliner | |
| NO174959C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater | |
| FI871087A7 (fi) | Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi |